These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12850550)

  • 1. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
    Samantaray S; Mohanakumar KP
    Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c mice.
    Samantaray S; Chandra G; Mohanakumar KP
    Neurosci Lett; 2003 May; 342(1-2):73-6. PubMed ID: 12727321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
    Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
    Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Przedborski S; Kostic V; Jackson-Lewis V; Naini AB; Simonetti S; Fahn S; Carlson E; Epstein CJ; Cadet JL
    J Neurosci; 1992 May; 12(5):1658-67. PubMed ID: 1578260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I; Langston JW; DeLanney LE
    Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
    J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.
    Royland JE; Delfani K; Langston JW; Janson AM; Di Monte DA
    Brain Res; 1999 Aug; 839(1):41-8. PubMed ID: 10482797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
    Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice.
    Fornai F; Alessandrì MG; Fascetti F; Vaglini F; Corsini GU
    J Neurochem; 1995 Aug; 65(2):704-9. PubMed ID: 7616226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.